ALB and glioblastoma: Bovine serum albumin (BSA) is garnering interest as a possible nanocarrier platform for improving treatment efficiency against problematic malignancies such as GBM, owing to its excellent compatibility with hydrophobic drugs and its ability to traverse the BBB [33].